Lifetime risk of coronary heart disease by cholesterol levels at selected ages.
about
Should women be offered cholesterol lowering drugs to prevent cardiovascular disease? YesUsing hypothetical data to assess the effect of numerical format and context on the perception of coronary heart disease risk.Longitudinal association of PCSK9 sequence variations with low-density lipoprotein cholesterol levels: the Coronary Artery Risk Development in Young Adults Study.Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosEffects of PCSK9 genetic variants on plasma LDL cholesterol levels and risk of premature myocardial infarction in the Italian populationComorbidity Cohort (2C) study: cardiovascular disease severity and comorbid osteoarthritis in primary care.Prevalence of risk factors at presentation and early mortality in patients aged 80 years or older with ST-segment elevation myocardial infarction.Is universal pediatric lipid screening justified?Implementation of permutation testing to determine clustering of social and behavioral risk factors for coronary heart disease, National Health and Nutrition Examination Survey 2001-2004Are statins indicated for the primary prevention of CAD in octogenarians? antagonist viewpoint.Risk factors for cardiovascular disease and hormone therapy in women.Lifetime risks of cardiovascular diseaseChanges in lipid profiles after switching to a protease inhibitor-containing cART--unfavourable effect of fosamprenavir in obese patients.Impact of adherence to statins on coronary artery disease in primary prevention.Changing trends (1986-2003) in the use of lipid lowering medication in patients hospitalized with acute myocardial infarction: a community-based perspective.Lifetime risk for cancer death by sex and smoking status: the lifetime risk pooling project.Lifetime risk of developing coronary heart disease in Aboriginal Australians: a cohort study.Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease.Recent Update to the US Cholesterol Treatment Guidelines: A Comparison With International Guidelines.Cardiovascular Disease Risk Assessment: Insights from Framingham.Efficacy and safety of statin monotherapy in older adults: a meta-analysis.Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels in the ATP-III risk assessment tool.Lifetime Risk for Sudden Cardiac Death in the CommunityPredicting the 30-year risk of cardiovascular disease: the framingham heart study.Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology.Social and behavioral risk marker clustering associated with biological risk factors for coronary heart disease: NHANES 2001-2004Inverse associations between perceived racism and coronary artery calcification.Modifiable risk factors in periodontitis: at the intersection of aging and disease.The importance of HDL-C and CRP in cardiovascular risk evaluation in longevous elderly individuals.What is the lifetime risk of physician-diagnosed asthma in Ontario, Canada?Optimal Target Level of Low-density Lipoprotein Cholesterol for Vascular Function in Statin Naïve Individuals.A Simple Community-Based Risk Prediction Score for Sudden Cardiac Death.Dyslipidaemia in the elderly: to treat or not to treat?Synergistic effect of coronary artery disease risk factors on long-term survival in patients with normal exercise SPECT studies.
P2860
Q24685830-C9D2FE3A-3C73-4FE1-9176-C532D6B8C510Q31153049-50A38AE9-F337-43F0-8398-EFA29925DEE2Q33605219-1FBF1BAC-1F02-441B-9A10-D2E5B3740542Q33718335-2694CE0B-E0D8-4522-9115-CD0A3D6FBD00Q34188099-735E9443-3C25-4094-BDC6-013CA1B44C76Q34400416-014AFF7F-05D1-4A20-BD1C-9C00FDEDBBFCQ34701292-CE7650F5-54D4-4B5C-9EB5-DF701A9EA3EAQ35146989-DC4193A1-7F80-46DF-9939-363563060E8EQ35492954-A29A039A-8C17-44B3-AA2D-C182CE77A3CAQ35580951-E01AB463-848E-4127-9A95-F47C7C2A141CQ35771145-E6701B80-7519-4FE0-AB17-198F55F7E454Q35913358-4841B335-5431-42C0-B24C-EBA99A2EDE58Q35963960-15FD00D6-B214-4804-8E26-59DA66CC8269Q36024456-82A4AD57-1CFA-4A66-A518-E89DC207ED1DQ36059776-C9B97463-AAD3-40DA-8040-783875963249Q36524525-DE4A1B9A-B687-4528-BDDA-869A810EAEBCQ36584107-880675DE-61B0-4581-BF69-AB8686EA01E6Q36593266-C9A0CD43-B84F-4156-BCA6-40A94E734685Q36873040-79C26CF9-5E7E-4989-A7C9-6BF8E8AE2D64Q36905510-F9DF6D6F-037D-4A46-8715-281B093CB634Q36912033-4BDDD9B4-8560-4125-A4CB-3137DD76B7ECQ37071583-D77E4226-CC54-4399-9979-81ADCEBD1358Q37240596-FB9B6E65-B1D6-44DC-BE11-F0F9793FC1AAQ37356527-580599CF-E50F-4C67-9394-D8D594A66251Q37503009-41B60139-F76A-4719-B213-B2B1EA93FDECQ37639889-A77BD18A-678B-4F10-B310-12EE2474D705Q37664328-187F6868-6466-4123-8A0B-223F79AB0BB4Q38169796-0BBD8575-E2F9-4538-BBE8-833653956413Q38694782-9C0AB21B-D300-4947-B7BF-2316B4038032Q39908488-36FF8E19-0E7B-45CE-A8BF-880FBD0819C3Q41484059-77B33C12-62FA-4B53-AAF5-D74A70C7A99FQ47223573-15B1D6EE-C07B-4998-B791-88AFA1932DDCQ50180407-F1E2B125-0057-44A3-8AE5-413739B7E015Q53253588-53E72ECC-AD70-4F22-BB66-ED82BED38104
P2860
Lifetime risk of coronary heart disease by cholesterol levels at selected ages.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Lifetime risk of coronary heart disease by cholesterol levels at selected ages.
@en
Lifetime risk of coronary heart disease by cholesterol levels at selected ages.
@nl
type
label
Lifetime risk of coronary heart disease by cholesterol levels at selected ages.
@en
Lifetime risk of coronary heart disease by cholesterol levels at selected ages.
@nl
prefLabel
Lifetime risk of coronary heart disease by cholesterol levels at selected ages.
@en
Lifetime risk of coronary heart disease by cholesterol levels at selected ages.
@nl
P2093
P50
P1476
Lifetime risk of coronary heart disease by cholesterol levels at selected ages.
@en
P2093
Daniel Levy
James I Cleeman
Peter W F Wilson
Ralph B D'Agostino
P304
P356
10.1001/ARCHINTE.163.16.1966
P407
P577
2003-09-01T00:00:00Z